130.116013

[Ãëàâíàÿ/Ïîèñê] [Ïðîèçâîäèòåëè] [Ìîñêâà] [Ñ-Ïá] [Äðóãèå] [Îáùèé] [Çàÿâêè] [Âûáîðêà]

Öåíû íà ÝÂÊÀËÈÏÒ (ÍÀÑÒÎÉÊÀ ÔË.25 ÌË ) - ÝÕÈÍÀÖÅß (ÍÀÑÒÎÉÊÀ 50 ÌË )

Ïðîäàâåö: Àéïàðà-ÑÏá (Ñàíêò-Ïåòåðáóðã,óë. Ìàðøàëà Ãîâîðîâà ä.29, ëèò.ÀÁ (812) 326-93-43, (812) 326-93-4)

ÍàèìåíîâàíèåÏðîèçâîäèòåëüÖåíà $Öåíà ðóá
ÝÂÊÀËÈÏÒ (ÍÀÑÒÎÉÊÀ ÔË.25 ÌË )ÝÊÎËÀÁ5.15
ÝÂÊÀËÈÏÒ-Ì (ÏÀÑÒÈËÊÈ ¹12 )NATUR PRODUKT EUROPE B.V.38.04
ÝÂÊÀËÈÏÒ-Ì (ÒÀÁË. ¹20 )NATUR PRODUKT EUROPE B.V.61.31
ÝÂÊÀËÈÏÒ-Ì ÏÀÑÒÈËÊÈ ¹24NATUR PRODUKT EUROPE B.V.69.41
ÝÃÈËÎÊ (ÒÀÁË. 25 ÌÃ ¹60 )EGIS90.61
ÝÃÈËÎÊ (ÒÀÁË. 50 ÌÃ ¹60 )EGIS109.93
ÝÃÈËÎÊ ÒÀÁË. 100 ÌÃ ¹60EGIS143.8
ÝÃËÎÍÈË ÒÀÁË. 200ÌÃ ¹12SANOFI-WINTHROP INDUSTRIE254.14
ÝÄÀÑ (ÑÈÐÎÏ 100 ÌË 306 ÏÀÑÑÀÌÁÐÀ )ÝÄÀÑ91.75
ÝÊÇÎÄÅÐÈË (Ð-Ð ÍÀÐÓÆÍ. 1 % 10 ÌË ÔËÀÊ)GLOBOPHARM/SANDOZ368
ÝÊÇÎÄÅÐÈË ÊÐÅÌ 1% 15ÃMERCK/SANDOZ241.89
ÝËÅÂÈÒ ÏÐÎÍÀÒÀËÜ ÒÀÁË. ¹100ROTTENDORF FARMA821.94
ÝËÅÂÈÒ ÏÐÎÍÀÒÀËÜ ÒÀÁË. ¹30ROTTENDORF FARMA295.04
ÝËÅÓÒÅÐÎÊÎÊÊ (ÝÊÑÒÐÀÊÒ ÆÈÄÊ. 50 ÌË )ÄÀËÜÕÈÌÔÀÐÌ22.53
ÝËÅÔËÎÊÑ (ÒÀÁË.Ï.Î. 500 ÌÃ ¹10 )RANBAXY716.08
ÝËÈÄÅË ÊÐÅÌ 1% 15ÃNOVARTIS PHARMA865
ÝËÎÊÎÌ ÊÐÅÌ 0,1% 15ÃSCHERING-PLOUGH LABO N.V.288.33
ÝËÎÊÎÌ ÌÀÇÜ 0,1 % 15 ÃSCHERING-PLOUGH LABO N.V.295.87
ÝËÜÊÀÐ (Ð-Ð 30 % 100 ÌË )ÏÈÊ-ÔÀÐÌÀ468.6
ÝËÜÊÀÐ (Ð-Ð 30 % 50 ÌË )ÏÈÊ-ÔÀÐÌÀ294.63
ÝËÜÌÀ ÌÀÑËÎ Ä/ÓÊÐÅÏËÅÍÈß ÐÅÑÍÈÖ ÔË. 10ÌËÄÈÍÀ+75.33
ÝÌËÀ (ÊÐÅÌ 5 % 5 Ã ¹5 )ASTRAZENECA/RECIP KARLSKOGA1062
ÝÌÎÊÑÈ-ÎÏÒÈÊ (ÊÀÏËÈ ÃËÀÇÍ. 1% 5 ÌË ÔËÀÊ)ÑÈÍÒÅÇ14.79
ÝÌÎÊÑÈÏÈÍ Ð-Ð Ä/ÈÍ. 1% 1ÌË ¹10ÌÎÑÊÎÂÑÊÈÉ ÝÍÄÎÊÐÈÍÍÛÉ ÇÀÂÎÄ73.86
ÝÍÀËÀÏÐÈË (ÒÀÁË. 10 ÌÃ ¹20 )HEMOFARM/ÕÅÌÎÔÀÐÌ ÎÎÎ50.06
ÝÍÀËÀÏÐÈË (ÒÀÁË. 20 ÌÃ ¹20 )ÎÇÎÍ ÎÎÎ8.84
ÝÍÀËÀÏÐÈË (ÒÀÁË. 5 ÌÃ ¹20 )ÕÅÌÎÔÀÐÌ ÎÎÎ34.65
ÝÍÀËÀÏÐÈË ÃÅÊÑÀË (ÒÀÁË. 5 ÌÃ ¹20 )HEXAL PHARMA/SALUTAS PHARMA42.04
ÝÍÀËÀÏÐÈË ÒÀÁ. 20ÌÃ ¹20HEMOFARM/ÕÅÌÎÔÀÐÌ ÎÎÎ79.38
ÝÍÀËÀÏÐÈË ÒÁ. 10 ÌÃ ¹20ÑÈÍÒÅÇ ÀÊÎ6.45
ÝÍÀÏ (ÒÀÁË. 10 ÌÃ ¹20 )KRKA64.98
ÝÍÀÏ (ÒÀÁË. 10 ÌÃ ¹20 )ÊRÊÀ-ÐÓÑ64.98
ÝÍÀÏ (ÒÀÁË. 5 ÌÃ ¹20 )KRKA-ÐÓÑ ÎÎÎ49.78
ÝÍÀÏ ÒÀÁË. 2,5 ÌÃ ¹20KRKA42.01
ÝÍÀÏ ÒÀÁË. 20 ÌÃ ¹20KRKA103.99
ÝÍÀÏ-HL (ÒÀÁË. 10 ÌÃ+12,5 ÌÃ ¹20 )KRKA87.63
ÝÍÀÏ-Í (ÒÀÁË. 10 ÌÃ+25 ÌÃ ¹20 )KRKA95.08
ÝÍÀÔÀÐÌ ÒÀÁË. 10 ÌÃ ¹20ÔÀÐÌÀÊÎÐ ÏÐÎÄÀÊØÍ13.38
ÝÍÀÔÀÐÌ ÒÀÁË. 20 ÌÃ ¹20ÔÀÐÌÀÊÎÐ ÏÐÎÄÀÊØÍ24.53
ÝÍÄÎÊÐÈÍÎË (ÊÀÏÑ. ¹30 )ÝÂÀËÀÐ ÇÀÎ102.34
ÝÍÇÈÊÑ ÄÓÎ ÒÀÁË. ¹45HEMOFARM/ÕÅÌÎÔÀÐÌ ÎÎÎ90.44
ÝÍÇÈÑÒÀË (ÒÀÁË.Ï/Î ¹20 )TORRENT60.56
ÝÍÒÅÐÎÄÅÇ (ÏÎÐ. 5 Ã )ÌÎÑÕÈÌÔÀÐÌÏÐÅÏÀÐÀÒÛ62.87
ÝÍÒÅÐÎË (ÊÀÏÑ. 250 ÌÃ ¹10 )LABORATOIRES BIOCODEX105.38
ÝÍÒÅÐÎË (ÊÀÏÑ. 250 ÌÃ ¹30 )LABORATOIRES BIOCODEX209.52
ÝÍÒÅÐÎÑÃÅËÜ ÃÅËÜ 225ÃÑÈËÌÀ155.97
ÝÍÒÅÐÎÔÓÐÈË (ÊÀÏÑ. 100 ÌÃ ¹30 )BOSNALIJEK150.91
ÝÍÒÅÐÎÔÓÐÈË (ÊÀÏÑ. 200 ÌÃ ¹16 )BOSNALIJEK165.82
ÝÍÒÅÐÎÔÓÐÈË ÑÓÑÏ. 200 ÌÃ/5 ÌË 90 ÌËBOSNALIJEK210.45
ÝÏÈÃÅÍ ÈÍÒÈÌ (ÑÏÐÅÉ 60 ÌË )CHEMINOVA INTERNACIONAL879.09
ÝÏÈÃÅÍ ÈÍÒÈÌ ÃÅËÜ 250 ÌË*375.47
ÝÏËÀÍ ÊÐÅÌ 30 ÃÎÁÅÐÎÍ ÍÏÏ/ÃÎÑÍÈÈÎÕÒ107.35
ÝÐÅÊÒÎÃÅÍÎÍ (ÊÀÏÑ. 500 ÌÃ ¹30 )ÂÈÑ ÎÎÎ514.78
ÝÐÅÑÏÀË (ÑÈÐÎÏ 0,2 % 150 ÌË )SERVIER208.5
ÝÐÅÑÏÀË (ÒÀÁË.Ï/Î 80 ÌÃ ¹30 )SERVIER274.37
ÝÐÈÍÈÒ (ÒÀÁË. 10 ÌÃ ¹50 )ÒÀÒÕÈÌÔÀÐÌÏÐÅÏÀÐÀÒÛ25.25
ÝÐÈÒÐÎÌÈÖÈÍ (ÌÀÇÜ 1% 15 Ã )ÁÈÎÑÈÍÒÅÇ ÎÎÎ12.13
ÝÐÈÒÐÎÌÈÖÈÍ (ÌÀÇÜ ÃËÀÇÍ. 1% 10 Ã )ÒÀÒÕÈÌÔÀÐÌÏÐÅÏÀÐÀÒÛ14.82
ÝÐÈÓÑ (ÑÈÐÎÏ 120 ÌË )SCHERING-PLOUGH541.76
ÝÐÈÓÑ (ÒÀÁË.Ï/Î 5 ÌÃ ¹10 )SCHERING-PLOUGH401.84
ÝÐÈÓÑ (ÒÀÁË.Ï/Î 5 ÌÃ ¹7 )SCHERING-PLOUGH278.77
ÝÐÈÓÑ ÑÈÐÎÏ 60ÌËSCHERING-PLOUGH371.21
ÝÐÑÅÔÓÐÈË (ÊÀÏÑ. 200 ÌÃ ¹28 )SANOFI/SYNTHELABO293.72
ÝÑÊÀÏÅË ÒÀÁË. 1,5 ÌÃ ¹1GEDEON RICHTER250.25
ÝÑÊÓÇÀÍ (Ð-Ð ÄËß ÏÐÈÅÌÀ ÂÍÓÒÐÜ 20 ÌË )WERNIGERODE PHARMA76.56
ÝÑÏÓÌÈÇÀÍ (ÝÌÓËÜÑÈß 40 ÌÃ 100 ÌË ÔËÀÊ)BERLIN-CHEMIE / MENARINI GROUP216
ÝÑÏÓÌÈÇÀÍ L (ÝÌÓËÜÑÈß 40 ÌÃ/ÌË 30 ÌË )BERLIN-CHEMIE217.06
ÝÑÏÓÌÈÇÀÍ ÊÀÏÑ. 40 ÌÃ ¹ 25BERLIN-CHEMIE AG/MENARINI GROUP125.36
ÝÑÑÅÍÖÈÀËÅ Í (Ð-Ð Ä/ÈÍ. ÀÌÏ. 250 ÌÃ 5ÌË ¹5 )SANOFI-AVENTIS511
ÝÑÑÅÍÖÈÀËÅ Í ÔÎÐÒÅ (ÊÀÏÑ. 300 ÌÃ ¹100 )AVENTIS/NATTERMANN GMBH1203
ÝÑÑÅÍÖÈÀËÅ Í ÔÎÐÒÅ ÊÀÏÑ. 300ÌÃ ¹30NATTERMANN GMBH359
ÝÑÑËÈÂÅÐ ÔÎÐÒÅ (ÊÀÏÑ. ¹30 )NABROS PHARMA/ÍÈÆÔÀÐÌ156.47
ÝÑÑËÈÂÅÐ ÔÎÐÒÅ (ÊÀÏÑ. ¹50 )NABROS PHARMA/ÍÈÆÔÀÐÌ205
ÝÒÀÖÈÇÈÍ (ÒÀÁË.Ï/Î 50 ÌÃ ¹50 )ÎËÀÉÍÑÊÈÉ ÕÔÇ515.1
ÝÓÁÈÊÎÐ (ÏÎÐ. 1,5 Ã ¹30 (Ä/ÄÅÒÅÉ) )ÂÀËÌÅÄ68.38
ÝÓÁÈÊÎÐ (ÏÎÐ. 3 Ã ¹30 )ÂÀËÌÅÄ94.5
ÝÓÁÈÊÎÐ (ÏÎÐ. 3 Ã ¹60 )ÂÀËÌÅÄ ÎÎÎ164
ÝÓÒÈÐÎÊÑ ÒÀÁË. 50 ÌÊÃ ¹100E MERCK96.81
ÝÓÔÎÐÁÈÓÌ ÊÎÌÏÎÇÈÒÓÌ ÍÀÇÅÍÒÐÎÏÔÅÍ Ñ (ÑÏÐÅÉ ÍÀÇÀËÜÍ. 20 ÌËHEEL219.29
ÝÔÔÅÐÀËÃÀÍ (ÑÓÏÏ.ÐÅÊÒ. 150 ÌÃ ¹10 )BRISTOL-MYERS SQUIBB42.07
ÝÔÔÅÐÀËÃÀÍ (ÑÓÏÏ.ÐÅÊÒ. 80 ÌÃ ¹10 )BRISTOL-MYERS SQUIBB39.84
ÝÔÔÅÐÀËÃÀÍ (ÒÀÁË.ØÈÏ. 500 ÌÃ ¹16 )BRISTOL-MYERS SQUIBB69.27
ÝÔÔÅÐÀËÃÀÍ (ÒÀÁË.ØÈÏ. ¹10 Ñ ÂÈÒÀÌÈÍÎÌ Ñ )BRISTOL-MYERS SQUIBB55.66
ÝÔÔÅÐÀËÃÀÍ ÑÓÏÏ. ÐÅÊÒ.300ÌÃ ¹10BRISTOL-MYERS SQUIBB49.61
ÝÕÈÍÀÖÅß (ÊÀÏÑ. ¹30 Ñ ÂÈÒ.Ñ )ÔÀÐÌÀÊÎÐ ÏÐÎÄÀÊØÍ68.01
ÝÕÈÍÀÖÅß (ÍÀÑÒÎÉÊÀ 50 ÌË )ÂÀÒÕÝÌ-ÔÀÐÌÀÖÈß21.17
ÝÕÈÍÀÖÅß (ÍÀÑÒÎÉÊÀ 50 ÌË )ÝÊÎËÀÁ30.75





2001-2011 http://www.med.sgg.ru - öåíû íà ëåêàðñòâà, ìåäòåõíèêó, âñå äëÿ ñòîìàòîëîãèè, õèðóðãè÷åñêèé è äðóãîé ìåäèöèíñêèé èíñòðóìåíò è òåõíèêà, ôàðìàöåâòè÷åñêèå ïðåïàðàòû è ñóáñòàíöèè îò ïðîèçâîäèòåëåé è îïòîâûõ ïðîäàâöîâ â Ìîñêâå, Ñàíêò-Ïåòåðáóðãå è äðóãèõ ðåãèîíàõ.



Rambler's Top100 Rambler's Top100 Ðåéòèíã@Mail.ru